Proteome Sciences (PRM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.43p
   
  • Change Today:
    -0.17p
  • 52 Week High: 8.50
  • 52 Week Low: 2.97
  • Currency: UK Pounds
  • Shares Issued: 295.18m
  • Volume: 50,346
  • Market Cap: £10.12m
  • RiskGrade: 353

Proteome stroke test could save thousands from brain damage

Date: Tuesday 18 Sep 2012

LONDON (ShareCast) - Medical technology group Proteome Sciences has released details of a study into a blood test which could reduce brain damage in thousands of stroke victims.

The group has been collaborating with researchers at the University of Geneva to produce the test which can tell how long ago a stroke actually took place.

The exact timing of a stroke has a big influence on the kind of therapy that is used to help patients recover. Treated quickly, the brain damage caused by strokes can be significantly reduced, but as many strokes take place during sleep, it is often difficult to know when the symptoms began.

During the study, scientists found one protein, known as GSTP, which showed an almost instantaneous increase in the blood of stroke patients, peaking at three hours after onset and returning to normal levels within around six hours.

Extrapolating the results across patients who were admitted to the Geneva Hospital in 2006/7 with suspected stroke, but who did not know when their stroke symptoms started, indicates that testing for GSTP could result in as many as five times more people being eligible for the highly effective “rt-PA” treatment, which can only be used within 4.5 hours of a stroke under UK medical guidelines.

The leader of the study, Professor Jean-Charles Sanchez, said: "This is a major step towards improving the management of ischaemic stroke patients using the drugs that we already have available. A simple blood test that matches the therapeutic window of rt-PA is a major advance."

Dr Peter Coleman, Deputy Director of Research at The Stroke Association agreed, adding: "When a stroke strikes, time lost is brain lost, meaning that getting to hospital and receiving treatment quickly is absolutely essential.

"A test such as this which could be used to quickly diagnose a stroke, possibly before a patient arrives at hospital, could speed up the treatment process and potentially improve outcomes.”

Proteome’s share price rose 3.2% on Tuesday morning and has now gained 63% in the last 12 months.

BS

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

PRM Market Data

Currency UK Pounds
Share Price 3.43p
Change Today -0.17p
% Change -4.72 %
52 Week High 8.50
52 Week Low 2.97
Volume 50,346
Shares Issued 295.18m
Market Cap £10.12m
RiskGrade 353

PRM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.46% below the market average15.46% below the market average15.46% below the market average15.46% below the market average15.46% below the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average
Price Trend
59.7% below the market average59.7% below the market average59.7% below the market average59.7% below the market average59.7% below the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average
Income Not Available
Growth
46.39% above the market average46.39% above the market average46.39% above the market average46.39% above the market average46.39% above the market average
76.47% above the sector average76.47% above the sector average76.47% above the sector average76.47% above the sector average76.47% above the sector average

PRM Dividends

No dividends found

Trades for 24-May-2024

Time Volume / Share Price
14:03 15,014 @ 3.41p
12:43 332 @ 3.91p
08:45 35,000 @ 3.54p

PRM Key Personnel

CFO Abdelghani Omari

Top of Page